1h Free Analyst Time
The cardiac monitoring and cardiac rhythm management devices market is forecasted to grow by USD 7.47 billion during 2023-2028, accelerating at a CAGR of 5.38% during the forecast period. The report on the cardiac monitoring and cardiac rhythm management devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of cvds globally, technological advances in cm and crm devices, and increasing uptake of mobile cardiac telemetry (mct).
The cardiac monitoring and cardiac rhythm management devices market is segmented as below:
By Product
- CRM devices
- CM devices
By End-user
- Hospitals
- clinics
- Cardiac care centers
- ASCs
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the cardiac monitoring and cardiac rhythm management devices market covers the following areas:
- Cardiac monitoring and cardiac rhythm management devices market sizing
- Cardiac monitoring and cardiac rhythm management devices market forecast
- Cardiac monitoring and cardiac rhythm management devices market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global cardiac monitoring and cardiac rhythm management devices market: Abbott Laboratories, Adaptive Biotechnologies Corp., Asahi Kasei Corp., BIOTRONIK SE and Co. KG, Boston Scientific Corp., BPL MEDICAL TECHNOLOGIES Pvt. Ltd., Cell Microsystems Inc., GE Healthcare Technologies Inc., Johnson and Johnson, Koninklijke Philips N.V., Medtronic Plc, MicroPort Scientific Corp., Nihon Kohden Corp., Osypka Medical GmBH, Progetti srl, QIAGEN NV, SCHILLER AG, Stryker Corp., ZOLL Medical Corp., and Shree Pacetronix Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing strategic initiatives by market vendors."
According to the report, one of the major drivers for this market is the increasing prevalence of cvds globally.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Adaptive Biotechnologies Corp.
- Asahi Kasei Corp.
- BIOTRONIK SE and Co. KG
- Boston Scientific Corp.
- BPL MEDICAL TECHNOLOGIES Pvt. Ltd.
- Cell Microsystems Inc.
- GE Healthcare Technologies Inc.
- Johnson and Johnson
- Koninklijke Philips N.V.
- Medtronic Plc
- MicroPort Scientific Corp.
- Nihon Kohden Corp.
- Osypka Medical GmBH
- Progetti srl
- QIAGEN NV
- SCHILLER AG
- Stryker Corp.
- ZOLL Medical Corp.
- Shree Pacetronix Ltd.
